HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ruichan Lv Selected Research

Lanthanoid Series Elements (Lanthanides)

11/2021MET-targeted NIR II luminescence diagnosis and up-conversion guided photodynamic therapy for triple-negative breast cancer based on a lanthanide nanoprobe.
7/2020Degradable pH-responsive NIR-II imaging probes based on a polymer-lanthanide composite for chemotherapy.
3/2020An optimized lanthanide-chlorophyll nanocomposite for dual-modal imaging-guided surgery navigation and anti-cancer theranostics.
5/2019Mesoporous semiconductors combined with up-conversion nanoparticles for enhanced photodynamic therapy under near infrared light.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ruichan Lv Research Topics

Disease

36Neoplasms (Cancer)
03/2022 - 11/2013
4Hyperthermia
11/2019 - 12/2014
3Squamous Cell Carcinoma of Head and Neck
03/2022 - 02/2021
2Neoplasm Metastasis (Metastasis)
02/2022 - 01/2021
1Starvation
02/2022
1Adenocarcinoma of Lung
02/2022
1Triple Negative Breast Neoplasms
11/2021
1Breast Neoplasms (Breast Cancer)
01/2021
1Hypoxia (Hypoxemia)
11/2019

Drug/Important Bio-Agent (IBA)

61-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2021 - 04/2017
5Pharmaceutical PreparationsIBA
07/2020 - 11/2013
4Therapeutic UsesIBA
02/2022 - 03/2016
4Lanthanoid Series Elements (Lanthanides)IBA
11/2021 - 05/2019
4cupric sulfide (CuS)IBA
01/2021 - 08/2015
4Doxorubicin (Adriamycin)FDA LinkGeneric
11/2015 - 11/2013
3Glutathione (Reduced Glutathione)IBA
03/2022 - 09/2016
3Peptides (Polypeptides)IBA
11/2021 - 11/2015
3PolymersIBA
07/2020 - 09/2015
3Photosensitizing Agents (Photosensitizers)IBA
05/2019 - 04/2017
3Reactive Oxygen Species (Oxygen Radicals)IBA
05/2019 - 06/2016
3ProdrugsIBA
01/2017 - 11/2015
2PlatinumIBA
09/2016 - 11/2015
2Silicon Dioxide (Silica)FDA LinkGeneric
09/2015 - 08/2015
1Fluorescent Dyes (Fluorescent Probes)IBA
03/2022
1Bevacizumab (Avastin)FDA Link
03/2022
1Cysteine (L-Cysteine)FDA Link
03/2022
1Proteins (Proteins, Gene)FDA Link
03/2022
1capmatinibIBA
03/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2022
1CoumarinsIBA
03/2022
1Deoxyglucose (2 Deoxy D glucose)IBA
02/2022
1Immune Checkpoint InhibitorsIBA
02/2022
1GoldIBA
01/2022
1AntibodiesIBA
01/2021
1Pentetic Acid (DTPA)FDA LinkGeneric
01/2021
1methoxypolyethyleneglycol- poly(lactic- co- glycolic acid)IBA
07/2020
1ChlorophyllIBA
03/2020
1IonsIBA
01/2020
1Phosphorus (Red Phosphorus)IBA
01/2020
1AcidsIBA
01/2020
1Free RadicalsIBA
11/2019
1Oxygen (Dioxygen)IBA
11/2019
1Drug CarriersIBA
11/2019
1Cisplatin (Platino)FDA LinkGeneric
09/2016
1Singlet OxygenIBA
06/2016
1MetalsIBA
12/2015
1Metal-Organic FrameworksIBA
12/2015
1Tuberculin (PPD)IBA
11/2015
1Biological ProductsIBA
09/2015
1Folic Acid (Vitamin M)FDA LinkGeneric
08/2015
1BromidesIBA
11/2013

Therapy/Procedure

19Therapeutics
02/2022 - 11/2013
8Lasers (Laser)
01/2021 - 03/2016
6Photochemotherapy (Photodynamic Therapy)
11/2021 - 04/2017
5Drug Therapy (Chemotherapy)
02/2022 - 07/2015
5Precision Medicine
02/2022 - 09/2015
3Intravenous Injections
03/2022 - 09/2016
3Immunotherapy
02/2022 - 01/2020
2Photothermal Therapy
01/2021 - 07/2015
2Phototherapy (Light Therapy)
11/2020 - 01/2020
1Molecular Targeted Therapy
01/2022
1Semiconductors
05/2019
1Intravenous Administration
03/2016
1Microspheres (Microsphere)
11/2015